These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


173 related items for PubMed ID: 11761996

  • 1. [Hepatocellular carcinoma in patients with parasitic liver disease--Japanese schistosomiasis and hepatocellular carcinoma].
    Akahane Y.
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():474-7. PubMed ID: 11761996
    [No Abstract] [Full Text] [Related]

  • 2. Impact of hepatitis C virus infection on schistosomal liver disease.
    Mohamed A, Elsheikh A, Ghandour Z, Al Karawi M.
    Hepatogastroenterology; 1998 Oct; 45(23):1492-6. PubMed ID: 9840092
    [Abstract] [Full Text] [Related]

  • 3. Chronic Japanese schistosomiasis and hepatocellular carcinoma: ten years of follow-up in Yamanashi Prefecture, Japan.
    Iida F, Iida R, Kamijo H, Takaso K, Miyazaki Y, Funabashi W, Tsuchiya K, Matsumoto Y.
    Bull World Health Organ; 1999 Oct; 77(7):573-81. PubMed ID: 10444881
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis B virus vs schistosomiasis and hepatocellular carcinoma in Saudi Arabia.
    Nouh MS, Bashi SA, Laajam MA, Mofleh IA, al-Aska A.
    East Afr Med J; 1990 Mar; 67(3):139-45. PubMed ID: 2162295
    [Abstract] [Full Text] [Related]

  • 5. Physiopathology of portal hypertension. Circulatory neophysiology after portacaval shunt.
    Leger L, Lenriot JP, Lemaigre G.
    Major Probl Clin Surg; 1974 Mar; 14():165-95. PubMed ID: 4359433
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical study on relationship between hepatocellular carcinoma and hepatitis C virus infection in patients with chronic liver disease].
    Sata M, Tokeshi S, Nakano H, Majima Y, Tanikawa K.
    Rinsho Byori; 1992 Sep; 40(9):929-34. PubMed ID: 1279247
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of hepatitis C infection and schistosomiasis in Egyptian patients with hepatocellular carcinoma.
    Mabrouk GM.
    Dis Markers; 1997 Nov; 13(3):177-82. PubMed ID: 9405930
    [Abstract] [Full Text] [Related]

  • 8. [From hepatitis to hepatocellular carcinoma].
    Omata M.
    Gan To Kagaku Ryoho; 1994 Aug; 21(10):1559-64. PubMed ID: 8060128
    [Abstract] [Full Text] [Related]

  • 9. [Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients].
    Tarao K, Ohkawa S, Tamai S, Shimizu A.
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):740-5. PubMed ID: 7563867
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Hepatic schistosomiasis. X-ray computed tomographic aspects. Apropos of 97 cases].
    Zhou KR, Jiang L, Diao WK.
    J Radiol; 1993 Sep; 74(6-7):325-9. PubMed ID: 8395601
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for hepatocellular carcinoma in Egypt: the role of hepatitis-B viral infection and schistosomiasis.
    Badawi AF, Michael MS.
    Anticancer Res; 1999 Sep; 19(5C):4565-9. PubMed ID: 10650811
    [Abstract] [Full Text] [Related]

  • 13. [Hepatitis C virus and hepatocellular carcinoma].
    Habscheid W.
    Dtsch Med Wochenschr; 1990 May 11; 115(19):758-9. PubMed ID: 2159872
    [No Abstract] [Full Text] [Related]

  • 14. [Risk factors for development of hepatocellular carcinoma in patients with liver cirrhosis associated with hepatitis C virus].
    Matsushita E, Unoura M, Kaneko S, Kobayashi K.
    Nihon Rinsho; 1995 Sep 11; 53 Suppl(Pt 1):727-30. PubMed ID: 7563864
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The clinical difference of HCV-related hepatocellular carcinoma and HBV-related hepatocellular carcinoma].
    Hayashi S, Saeki S, Tanaka T, Shibayama T, Ohtake H, Tanaka S.
    Nihon Rinsho; 1995 Sep 11; 53 Suppl(Pt 1):770-6. PubMed ID: 7563873
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Chronic liver diseases and hepatocellular carcinoma].
    Dtsch Med Wochenschr; 1994 Mar 25; 119(12):443. PubMed ID: 8143566
    [No Abstract] [Full Text] [Related]

  • 19. [Incidence of hepatocellular carcinoma in patients treated with interferon].
    Yokosuka O, Omata M.
    Nihon Rinsho; 1995 Sep 25; 53 Suppl(Pt 1):805-9. PubMed ID: 7563880
    [No Abstract] [Full Text] [Related]

  • 20. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
    Elsammak MY, Amin GM, Khalil GM, Ragab WS, Abaza MM.
    Clin Biochem; 2006 Jun 25; 39(6):623-9. PubMed ID: 16624274
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.